ABSTRACT
Objective To study on the clinical curative effect of artificial tear gel combined with Diclofenac Sodium Eye Drops for the treatment of xeroma. Methods 62 cases of patients from March 2014 to December 2015 were grouped and treated with different methods, After the treatment, the content of the evaluation index was statistically analyzed. Results The treatment of artificial tear gel combined with Diclofenac Sodium Eye Drops total effective rate of treatment was 93.55% in the control group than the treatment with Diclofenac Sodium Eye Drops 80.65% (P<0.05); the cure rate of the observation group, fluorescein staining rate, the normal rate of tear secretion, tear normal rate was better than the control group (P<0.05); all have statistical significance. Conclusion Xeroma were treated by artificial tears treatment gel combined with Diclofenac Sodium Eye Drops, higher cure rate and total effective rate of treatment can be obtained, has a high therapeutic value, Worthy of clinical popularization and Application.
ABSTRACT
Objective To study on the clinical curative effect of artificial tear gel combined with Diclofenac Sodium Eye Drops for the treatment of xeroma. Methods 62 cases of patients from March 2014 to December 2015 were grouped and treated with different methods, After the treatment, the content of the evaluation index was statistically analyzed. Results The treatment of artificial tear gel combined with Diclofenac Sodium Eye Drops total effective rate of treatment was 93.55% in the control group than the treatment with Diclofenac Sodium Eye Drops 80.65% (P<0.05); the cure rate of the observation group, fluorescein staining rate, the normal rate of tear secretion, tear normal rate was better than the control group (P<0.05); all have statistical significance. Conclusion Xeroma were treated by artificial tears treatment gel combined with Diclofenac Sodium Eye Drops, higher cure rate and total effective rate of treatment can be obtained, has a high therapeutic value, Worthy of clinical popularization and Application.